iOmx Therapeutics Initiates Phase Ib with OMX-0407
August 22, 2024 04:00 ET
|
iOmx Therapeutics AG
Data from the successful Phase Ia dose escalation study showed that OMX-0407 monotherapy demonstrated a favorable safety profile and signs of anti-tumor activity, with one durable complete response in...
Brachytherapy Devices Market Poised to Grow to US$ 1.9 Bn by 2034, With a 5.9% CAGR: Exclusive Report by Transparency Market Research, Inc.
August 15, 2024 06:45 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 15, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global brachytherapy...
Groundbreaking Voice of the Patient Report for pediatric low-grade glioma (pLGG) published by Pediatric Brain Tumor Foundation
August 07, 2024 09:30 ET
|
Pediatric Brain Tumor Foundation
Report documents the experiences of pLGG patients, survivors, their families, to inform future drug development for most common brain tumor type in kids
ICPO Foundation kooperiert mit dem American Hospital Dubai, um ein ICPO Collaborating Center im Nahen Osten zu etablieren.
July 11, 2024 00:00 ET
|
ICPO Foundation
Diese Kooperation stärkt die globalen Bildungsstandards für Radiotheranostics und wird den Patientenzugang zu einer neuen Generation effektiver Krebstherapien in den Vereinigten Arabischen Emiraten...
ICPO Foundation partners with the American Hospital Dubai to establish an ICPO Collaborating Center in the Middle East.
July 11, 2024 00:00 ET
|
ICPO Foundation
This cooperation strengthens global educational standards for radiotheranostics and will scale patient access to a new generation of effective cancer therapeutics in United Arabic Emirates. July 11,...
ICPO Foundation kooperiert mit Nuclear Medicine Research Infrastructure (NuMeRI), um ein ICPO Collaborating Center zu etablieren
July 04, 2024 00:00 ET
|
ICPO Foundation
Diese Zusammenarbeit verbessert die globalen Bildungsstandards in der Radiotheranostik und zielt darauf ab, den Zugang der Patienten zu einer neuen Ära effektiver Krebstherapien in Südafrika zu...
ICPO Foundation partners with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center
July 04, 2024 00:00 ET
|
ICPO Foundation
This collaboration enhances global educational benchmarks in radiotheranostics and aims to expand patient access to a new era of effective cancer therapeutics in South Africa. July 4, 2024 –...
Save the date: Die neue Ära der Krebsbehandlung wird präsentiert auf dem ICPO Theranostics Virtual Summit, 14. - 15. November 2024
June 27, 2024 00:00 ET
|
ICPO Foundation
Die neue Ära der Krebsbehandlung wird präsentiert auf dem ICPO Theranostics Virtual Summit, 14. - 15. November 2024 Die ICPO Foundation bietet ein erstklassiges wissenschaftliches Programm, das...
Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024
June 27, 2024 00:00 ET
|
ICPO Foundation
Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024 The ICPO Foundation offers a world-class scientific...
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
May 06, 2024 08:00 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...